Sensimed
Lausanne, CH · 1 known investors
Sensimed SA develops the SENSIMED Triggerfish, a non-invasive soft contact lens-based device that automatically records continuous ocular dimensional changes over 24 hours to support glaucoma management. The company centralizes and analyzes this data on a registry to help ophthalmologists differentiate indications, personalize treatment, and assess treatment efficacy.
Investors · 1
Frequently asked questions
- What does Sensimed do?
- Sensimed SA develops the SENSIMED Triggerfish, a non-invasive soft contact lens-based device that automatically records continuous ocular dimensional changes over 24 hours to support glaucoma management. The company centralizes and analyzes this data on a registry to help ophthalmologists differentiate indications, personalize treatment, and assess treatment efficacy.
- Who are Sensimed's investors?
- Sensimed's investors include Agate Medical Investments LP.
- Where is Sensimed headquartered?
- Sensimed is headquartered in Lausanne, CH.